Clinical characteristics of chronic liver disease with coronavirus disease 2019 (COVID-19): a cohort study in Wuhan, China
- PMID: 32855361
- PMCID: PMC7485721
- DOI: 10.18632/aging.103632
Clinical characteristics of chronic liver disease with coronavirus disease 2019 (COVID-19): a cohort study in Wuhan, China
Abstract
Background: Previous work has described acute liver injury (ALI) in coronavirus disease 2019 (COVID-19) pneumonia patients, However, there is limited analyses available investigating chronic liver disease (CLD) in COVID-19 patients. This study aimed to investigate clinical characteristics and outcomes of CLD confirmed in COVID-19 patients.
Results: A total of 104 cases (each group containing 52 patients) were analyzed in this study. The CLD group showed an average of 14 (10.0~21.2) length of stay (LOS) days, compared to the group without CLD that only showed an average of 12.5 (10~16) LOS days (Relative Risk [RR] = 1.34, 95% CI (1.22~1.48), P<0.001; Adjusted Relative Risk was 1.24 (95% CI: 1.12~1.39)). The CLD group contained a higher mortality rate and slight liver injury. Furthermore, COX regression model analyses suggested that the neutrophil-to-lymphocyte ratio (NLR) was an independent predictor of mortality risk (P < 0.001) in the CLD group. Additionally, a high NLR significantly correlated with a shorter overall survival (P <0.001).
Conclusions: COVID-19 patients also diagnosed with CLD suffered longer LOS, slight liver injuries and a higher mortality when compared to COVID-19 patients without CLD. The NLR was an independent risk factor for in-hospital deaths. Increased expression of NLR was an indicator of poor prognosis in COVID-19 patients with CLD. Thus, COVID-19 patients diagnosed with CLD and who show a higher NLR need additional care.
Methods: A retrospective cohort study was performed at the Wuhan Jin Yin-tan Hospital from February 2, 2020 to April 2, 2020. COVID-19 patients diagnosed with CLD or not diagnosed with CLD were enrolled in this study. The clinical characteristics and outcomes of these patients were compared.
Keywords: COVID-19; LOS; NLR; mortality; severity.
Conflict of interest statement
Figures
Similar articles
-
Liver damage at admission is an independent prognostic factor for COVID-19.J Dig Dis. 2020 Sep;21(9):512-518. doi: 10.1111/1751-2980.12925. J Dig Dis. 2020. PMID: 32713118
-
Ratios of neutrophil-to-lymphocyte and platelet-to-lymphocyte predict all-cause mortality in inpatients with coronavirus disease 2019 (COVID-19): a retrospective cohort study in a single medical centre.Epidemiol Infect. 2020 Sep 9;148:e211. doi: 10.1017/S0950268820002071. Epidemiol Infect. 2020. PMID: 32900409 Free PMC article.
-
Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19.J Infect. 2020 Jul;81(1):e6-e12. doi: 10.1016/j.jinf.2020.04.002. Epub 2020 Apr 10. J Infect. 2020. PMID: 32283162 Free PMC article.
-
Predictive values of neutrophil-to-lymphocyte ratio on disease severity and mortality in COVID-19 patients: a systematic review and meta-analysis.Crit Care. 2020 Nov 16;24(1):647. doi: 10.1186/s13054-020-03374-8. Crit Care. 2020. PMID: 33198786 Free PMC article.
-
Prevalence of chronic liver disease in patients with COVID-19 and their clinical outcomes: a systematic review and meta-analysis.Hepatol Int. 2020 Sep;14(5):612-620. doi: 10.1007/s12072-020-10078-2. Epub 2020 Jul 28. Hepatol Int. 2020. PMID: 32725453 Free PMC article.
Cited by
-
The association of chronic liver disorders with exacerbation of symptoms and complications related to COVID-19: A systematic review and meta-analysis of cohort studies.Clin Respir J. 2022 Dec;16(12):777-792. doi: 10.1111/crj.13552. Epub 2022 Oct 18. Clin Respir J. 2022. PMID: 36254683 Free PMC article.
-
Predictors of Length of Hospital Stay, Mortality, and Outcomes Among Hospitalised COVID-19 Patients in Saudi Arabia: A Cross-Sectional Study.J Multidiscip Healthc. 2021 Apr 15;14:839-852. doi: 10.2147/JMDH.S304788. eCollection 2021. J Multidiscip Healthc. 2021. PMID: 33883900 Free PMC article.
-
COVID-19 Severity and Mortality Among Chronic Liver Disease Patients: A Systematic Review and Meta-Analysis.Prev Chronic Dis. 2022 Aug 25;19:E53. doi: 10.5888/pcd19.210228. Prev Chronic Dis. 2022. PMID: 36007255 Free PMC article.
-
The role of type I interferon in the treatment of COVID-19.J Med Virol. 2022 Jan;94(1):63-81. doi: 10.1002/jmv.27317. Epub 2021 Sep 17. J Med Virol. 2022. PMID: 34468995 Free PMC article. Review.
-
Critically Ill COVID-19 Patient with Chronic Liver Disease - Insights into a Comprehensive Liver Intensive Care.J Clin Transl Hepatol. 2021 Aug 28;9(4):576-586. doi: 10.14218/JCTH.2020.00110. Epub 2021 Apr 28. J Clin Transl Hepatol. 2021. PMID: 34447688 Free PMC article. Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous